158 related articles for article (PubMed ID: 35739205)
1. Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study.
Gupta A; Saraiya V; Deveaux A; Oyekunle T; Jackson KD; Salako O; Daramola A; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Akinyemiju T
Sci Rep; 2022 Jun; 12(1):10631. PubMed ID: 35739205
[TBL] [Abstract][Full Text] [Related]
2. Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.
Akinyemiju T; Jones K; Gupta A; Oyekunle T; Saraiya V; Deveaux A; Salako O; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; ; Daramola A
BMC Cancer; 2021 Sep; 21(1):1051. PubMed ID: 34563146
[TBL] [Abstract][Full Text] [Related]
3. Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study.
Gupta A; Oyekunle T; Salako O; Daramola A; Alatise O; Ogun G; Adeniyi A; Deveaux A; Saraiya V; Hall A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Akinyemiju T
Oncotarget; 2021 Jun; 12(13):1230-1242. PubMed ID: 34194621
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
Akinyemiju T; Oyekunle T; Salako O; Gupta A; Alatise O; Ogun G; Adeniyi A; Deveaux A; Hall A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Daramola A
Clin Breast Cancer; 2022 Jun; 22(4):e463-e472. PubMed ID: 34980540
[TBL] [Abstract][Full Text] [Related]
5. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
[TBL] [Abstract][Full Text] [Related]
6. Could Anthropometric and Lipid Parameters Reflect Susceptibility to Breast Cancer? Comparison of Newly Diagnosed Breast Cancer and Apparently Healthy Women.
Akalanka HMK; Ekanayake S; Samarasinghe K
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2475-2480. PubMed ID: 30255702
[TBL] [Abstract][Full Text] [Related]
7. Correlations between serum lipid and Ki-67 levels in different breast cancer molecular subcategories.
Sun XB; Liu WW; Wang B; Yang ZP; Tang HZ; Lu S; Wang YY; Qu JX; Rao BQ
Oncol Lett; 2023 Feb; 25(2):53. PubMed ID: 36644143
[TBL] [Abstract][Full Text] [Related]
8. The association between serum lipid levels and histological type of breast cancer.
Wang X; Wang Y; Wang M; Chen X; Cui W; Chen X
Eur J Med Res; 2022 Aug; 27(1):154. PubMed ID: 35986413
[TBL] [Abstract][Full Text] [Related]
9. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
Lofterød T; Mortensen ES; Nalwoga H; Wilsgaard T; Frydenberg H; Risberg T; Eggen AE; McTiernan A; Aziz S; Wist EA; Stensvold A; Reitan JB; Akslen LA; Thune I
BMC Cancer; 2018 Jun; 18(1):654. PubMed ID: 29902993
[TBL] [Abstract][Full Text] [Related]
10. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Brouckaert O; Rudolph A; Laenen A; Keeman R; Bolla MK; Wang Q; Soubry A; Wildiers H; Andrulis IL; Arndt V; Beckmann MW; Benitez J; Blomqvist C; Bojesen SE; Brauch H; Brennan P; Brenner H; Chenevix-Trench G; Choi JY; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Eriksson M; Fasching PA; Figueroa J; Flyger H; Giles GG; González-Neira A; Guénel P; Hall P; Hollestelle A; Hopper JL; Ito H; Jones M; Kang D; ; Knight JA; Kosma VM; Li J; Lindblom A; Lilyquist J; Lophatananon A; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Muir K; Nevanlinna H; Peterlongo P; Pylkäs K; Saajrang S; Seynaeve C; Shen CY; Shu XO; Southey MC; Swerdlow A; Teo SH; Tollenaar RAEM; Truong T; Tseng CC; van den Broek AJ; van Deurzen CHM; Winqvist R; Wu AH; Yip CH; Yu JC; Zheng W; Milne RL; Pharoah PDP; Easton DF; Schmidt MK; Garcia-Closas M; Chang-Claude J; Lambrechts D; Neven P
Breast Cancer Res; 2017 Nov; 19(1):119. PubMed ID: 29116004
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for breast cancer and their association with molecular subtypes in a population of Northeast Brazil.
Gomes KAL; de Araújo Jerônimo AF; Guimarães CMC; de Oliveira Ramos R; Dos Santos Andrade LS; Weller M
Cancer Epidemiol; 2022 Jun; 78():102166. PubMed ID: 35486969
[TBL] [Abstract][Full Text] [Related]
13. Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study.
Okekunle AP; Yie GE; Song S; Kim Z; Youn HJ; Cho J; Min JW; Kim YS; Lee JE
Lipids Health Dis; 2022 Aug; 21(1):66. PubMed ID: 35918691
[TBL] [Abstract][Full Text] [Related]
14. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.
Melvin JC; Garmo H; Holmberg L; Hammar N; Walldius G; Jungner I; Lambe M; Van Hemelrijck M
BMC Cancer; 2017 Apr; 17(1):246. PubMed ID: 28376727
[TBL] [Abstract][Full Text] [Related]
15. Maternal lipid profile in pregnancy and embryonic size: a population-based prospective cohort study.
Gootjes DV; Posthumus AG; Wols DF; de Rijke YB; Roeters Van Lennep JE; Steegers EAP
BMC Pregnancy Childbirth; 2022 Apr; 22(1):333. PubMed ID: 35436866
[TBL] [Abstract][Full Text] [Related]
16. Lipid biomarkers and long-term risk of cancer in the Women's Health Study.
Chandler PD; Song Y; Lin J; Zhang S; Sesso HD; Mora S; Giovannucci EL; Rexrode KE; Moorthy MV; Li C; Ridker PM; Lee IM; Manson JE; Buring JE; Wang L
Am J Clin Nutr; 2016 Jun; 103(6):1397-407. PubMed ID: 27099252
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors.
Sawada MIBAC; de Fátima Mello Santana M; Reis M; de Assis SIS; Pereira LA; Santos DR; Nunes VS; Correa-Giannella MLC; Gebrim LH; Passarelli M
Sci Rep; 2023 Jun; 13(1):8998. PubMed ID: 37268673
[TBL] [Abstract][Full Text] [Related]
18. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women.
Rweyemamu LP; Akan G; Adolf IC; Magorosa EP; Mosha IJ; Dharsee N; Namkinga LA; Lyantagaye SL; Nateri AS; Atalar F
BMC Womens Health; 2021 Dec; 21(1):423. PubMed ID: 34930226
[TBL] [Abstract][Full Text] [Related]
19. The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer.
Campos AL; Sawada MIBAC; Santana MFM; Iborra RT; de Assis SIS; Reis M; de Carvalho JX; Gebrim LH; Passarelli M
Front Oncol; 2023; 13():1111094. PubMed ID: 36969000
[TBL] [Abstract][Full Text] [Related]
20. Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.
Llanos AA; Chandwani S; Bandera EV; Hirshfield KM; Lin Y; Ambrosone CB; Demissie K
Cancer Causes Control; 2015 Dec; 26(12):1737-50. PubMed ID: 26376894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
